Report cover image

Single-use Bioreactors Market (Product Type: Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Others; and Cell Type: Mammalian Cells, Bacterial Cells, Yeast Cells, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, a

Published Apr 04, 2024
Length 170 Pages
SKU # TNPR18827797

Description

Single-use Bioreactors Market (Product Type: Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Others; and Cell Type: Mammalian Cells, Bacterial Cells, Yeast Cells, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Single-Use Bioreactors Market – Scope of Report

TMR’s report on the global single-use bioreactors market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global single-use bioreactors market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global single-use bioreactors market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the single-use bioreactors market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global single-use bioreactors market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global single-use bioreactors market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global single-use bioreactors market.

The report delves into the competitive landscape of the global single-use bioreactors market. Key players operating in the global single-use bioreactors market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global single-use bioreactors market profiled in this report.

Key Questions Answered in Global single-use bioreactors Market Report
  • What is the sales/revenue generated by single-use bioreactors across all regions during the forecast period?
  • What are the opportunities in the global single-use bioreactors market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Single-Use Bioreactors Market – Research Objectives and Research Approach

The comprehensive report on the global single-use bioreactors market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global single-use bioreactors market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global single-use bioreactors market.

Table of Contents

170 Pages
1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Single-use Bioreactors Market
4. Market Overview
  4.1. Introduction
  4.1.1. Product Definition
  4.1.2. Industry Evolution / Developments
  4.2. Overview
  4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
  4.4. Global Single-use Bioreactors Market Analysis and Forecast, 2020-2034
5. Key Insights
  5.1. Pipeline Analysis
  5.2. Key Product/Brand Analysis
  5.3. Key Mergers & Acquisitions
  5.4. COVID-19 Pandemic Impact on Industry
6. Global Single-use Bioreactors Market Analysis and Forecast, by Product Type
  6.1. Introduction and Definitions
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Product Type, 2020-2034
  6.3.1. Single-use Bioreactor Systems
  6.3.2. Media Bags
  6.3.3. Filtration Assemblies
  6.3.4. Others
  6.4. Market Attractiveness, by Product Type
7. Global Single-use Bioreactors Market Analysis and Forecast, by Cell Type
  7.1. Introduction and Definitions
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Cell Type, 2020-2034
  7.3.1. Mammalian Cells
  7.3.2. Bacterial Cells
  7.3.3. Yeast Cells
  7.3.4. Others
  7.4. Market Attractiveness, by Cell Type
8. Global Single-use Bioreactors Market Analysis and Forecast, by Molecule Type
  8.1. Introduction and Definitions
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by Molecule Type, 2020-2034
  8.3.1. Monoclonal Antibodies (MABs)
  8.3.2. Vaccines
  8.3.3. Stem Cells
  8.3.4. Gene-modified Cells
  8.3.5. Others
  8.4. Market Attractiveness, by Molecule Type
9. Global Single-use Bioreactors Market Analysis and Forecast, by End-user
  9.1. Introduction and Definitions
  9.2. Key Findings/Developments
  9.3. Market Value Forecast, by End-user, 2020-2034
  9.3.1. Biopharmaceutical Companies
  9.3.2. Biotechnology Companies
  9.3.3. Others
  9.4. Market Attractiveness, by End-user
10. Global Single-use Bioreactors Market Analysis and Forecast, by Region
  10.1. Key Findings
  10.2. Market Value Forecast, by Region, 2020-2034
  10.2.1. North America
  10.2.2. Europe
  10.2.3. Asia Pacific
  10.2.4. Latin America
  10.2.5. Middle East & Africa
  10.3. Market Attractiveness, by Region
11. North America Single-use Bioreactors Market Analysis and Forecast
  11.1. Introduction
  11.1.1. Key Findings
  11.2. Market Value Forecast, by Product Type, 2020-2034
  11.2.1. Single-use Bioreactor Systems
  11.2.2. Media Bags
  11.2.3. Filtration Assemblies
  11.2.4. Others
  11.3. Market Attractiveness, by Product Type
  11.4. Market Value Forecast, by Cell Type, 2020-2034
  11.4.1. Mammalian Cells
  11.4.2. Bacterial Cells
  11.4.3. Yeast Cells
  11.4.4. Others
  11.5. Market Attractiveness, by Cell Type
  11.6. Market Value Forecast, by Molecule Type, 2020-2034
  11.6.1. Monoclonal Antibodies (MABs)
  11.6.2. Vaccines
  11.6.3. Stem Cells
  11.6.4. Gene-modified Cells
  11.6.5. Others
  11.7. Market Attractiveness, by Molecule Type
  11.8. Market Value Forecast, by End-user, 2020-2034
  11.8.1. Biopharmaceutical Companies
  11.8.2. Biotechnology Companies
  11.8.3. Others
  11.9. Market Attractiveness, by End-user
  11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
  11.10.1. U.S.
  11.10.2. Canada
  11.11. Market Attractiveness Analysis
  11.11.1. By Product Type
  11.11.2. By Cell Type
  11.11.3. By Molecule Type
  11.11.4. By End-user
  11.11.5. By Country
12. Europe Single-use Bioreactors Market Analysis and Forecast
  12.1. Introduction
  12.1.1. Key Findings
  12.2. Market Value Forecast, by Product Type, 2020-2034
  12.2.1. Single-use Bioreactor Systems
  12.2.2. Media Bags
  12.2.3. Filtration Assemblies
  12.2.4. Others
  12.3. Market Attractiveness, by Product Type
  12.4. Market Value Forecast, by Cell Type, 2020-2034
  12.4.1. Mammalian Cells
  12.4.2. Bacterial Cells
  12.4.3. Yeast Cells
  12.4.4. Others
  12.5. Market Attractiveness, by Cell Type
  12.6. Market Value Forecast, by Molecule Type, 2020-2034
  12.6.1. Monoclonal Antibodies (MABs)
  12.6.2. Vaccines
  12.6.3. Stem Cells
  12.6.4. Gene-modified Cells
  12.6.5. Others
  12.7. Market Attractiveness, by Molecule Type
  12.8. Market Value Forecast, by End-user, 2020-2034
  12.8.1. Biopharmaceutical Companies
  12.8.2. Biotechnology Companies
  12.8.3. Others
  12.9. Market Attractiveness, by End-user
  12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
  12.10.1. Germany
  12.10.2. U.K.
  12.10.3. France
  12.10.4. Italy
  12.10.5. Spain
  12.10.6. Rest of Europe
  12.11. Market Attractiveness Analysis
  12.11.1. By Product Type
  12.11.2. By Cell Type
  12.11.3. By Molecule Type
  12.11.4. By End-user
  12.11.5. By Country/Sub-region
13. Asia Pacific Single-use Bioreactors Market Analysis and Forecast
  13.1. Introduction
  13.1.1. Key Findings
  13.2. Market Value Forecast, by Product Type, 2020-2034
  13.2.1. Single-use Bioreactor Systems
  13.2.2. Media Bags
  13.2.3. Filtration Assemblies
  13.2.4. Others
  13.3. Market Attractiveness, by Product Type
  13.4. Market Value Forecast, by Cell Type, 2020-2034
  13.4.1. Mammalian Cells
  13.4.2. Bacterial Cells
  13.4.3. Yeast Cells
  13.4.4. Others
  13.5. Market Attractiveness, by Cell Type
  13.6. Market Value Forecast, by Molecule Type, 2020-2034
  13.6.1. Monoclonal Antibodies (MABs)
  13.6.2. Vaccines
  13.6.3. Stem Cells
  13.6.4. Gene-modified Cells
  13.6.5. Others
  13.7. Market Attractiveness, by Molecule Type
  13.8. Market Value Forecast, by End-user, 2020-2034
  13.8.1. Biopharmaceutical Companies
  13.8.2. Biotechnology Companies
  13.8.3. Others
  13.9. Market Attractiveness, by End-user
  13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
  13.10.1. China
  13.10.2. Japan
  13.10.3. India
  13.10.4. Australia & New Zealand
  13.10.5. Rest of Asia Pacific
  13.11. Market Attractiveness Analysis
  13.11.1. By Product Type
  13.11.2. By Cell Type
  13.11.3. By Molecule Type
  13.11.4. By End-user
  13.11.5. By Country/Sub-region
14. Latin America Single-use Bioreactors Market Analysis and Forecast
  14.1. Introduction
  14.1.1. Key Findings
  14.2. Market Value Forecast, by Product Type, 2020-2034
  14.2.1. Single-use Bioreactor Systems
  14.2.2. Media Bags
  14.2.3. Filtration Assemblies
  14.2.4. Others
  14.3. Market Attractiveness, by Product Type
  14.4. Market Value Forecast, by Cell Type, 2020-2034
  14.4.1. Mammalian Cells
  14.4.2. Bacterial Cells
  14.4.3. Yeast Cells
  14.4.4. Others
  14.5. Market Attractiveness, by Cell Type
  14.6. Market Value Forecast, by Molecule Type, 2020-2034
  14.6.1. Monoclonal Antibodies (MABs)
  14.6.2. Vaccines
  14.6.3. Stem Cells
  14.6.4. Gene-modified Cells
  14.6.5. Others
  14.7. Market Attractiveness, by Molecule Type
  14.8. Market Value Forecast, by End-user, 2020-2034
  14.8.1. Biopharmaceutical Companies
  14.8.2. Biotechnology Companies
  14.8.3. Others
  14.9. Market Attractiveness, by End-user
  14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
  14.10.1. Brazil
  14.10.2. Mexico
  14.10.3. Rest of Latin America
  14.11. Market Attractiveness Analysis
  14.11.1. By Product Type
  14.11.2. By Cell Type
  14.11.3. By Molecule Type
  14.11.4. By End-user
  14.11.5. By Country/Sub-region
15. Middle East & Africa Single-use Bioreactors Market Analysis and Forecast
  15.1. Introduction
  15.1.1. Key Findings
  15.2. Market Value Forecast, by Product Type, 2020-2034
  15.2.1. Single-use Bioreactor Systems
  15.2.2. Media Bags
  15.2.3. Filtration Assemblies
  15.2.4. Others
  15.3. Market Attractiveness, by Product Type
  15.4. Market Value Forecast, by Cell Type, 2020-2034
  15.4.1. Mammalian Cells
  15.4.2. Bacterial Cells
  15.4.3. Yeast Cells
  15.4.4. Others
  15.5. Market Attractiveness, by Cell Type
  15.6. Market Value Forecast, by Molecule Type, 2020-2034
  15.6.1. Monoclonal Antibodies (MABs)
  15.6.2. Vaccines
  15.6.3. Stem Cells
  15.6.4. Gene-modified Cells
  15.6.5. Others
  15.7. Market Attractiveness, by Molecule Type
  15.8. Market Value Forecast, by End-user, 2020-2034
  15.8.1. Biopharmaceutical Companies
  15.8.2. Biotechnology Companies
  15.8.3. Others
  15.9. Market Attractiveness, by End-user
  15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
  15.10.1. GCC Countries
  15.10.2. South Africa
  15.10.3. Rest of Middle East & Africa
  15.11. Market Attractiveness Analysis
  15.11.1. By Product Type
  15.11.2. By Cell Type
  15.11.3. By Molecule Type
  15.11.4. By End-user
  15.11.5. By Country/Sub-region
16. Competition Landscape
  16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  16.2. Market Share Analysis, by Company (2023)
  16.3. Company Profiles
  16.3.1. Danaher Corporation
  16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.1.2. Product Portfolio
  16.3.1.3. Financial Overview
  16.3.1.4. SWOT Analysis
  16.3.1.5. Strategic Overview
  16.3.2. General Electric Company
  16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.2.2. Product Portfolio
  16.3.2.3. Financial Overview
  16.3.2.4. SWOT Analysis
  16.3.2.5. Strategic Overview
  16.3.3. Merck KGaA
  16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.3.2. Product Portfolio
  16.3.3.3. Financial Overview
  16.3.3.4. SWOT Analysis
  16.3.3.5. Strategic Overview
  16.3.4. Sartorius AG
  16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.4.2. Product Portfolio
  16.3.4.3. Financial Overview
  16.3.4.4. SWOT Analysis
  16.3.4.5. Strategic Overview
  16.3.5. Thermo Fisher Scientific, Inc.
  16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.5.2. Product Portfolio
  16.3.5.3. Financial Overview
  16.3.5.4. SWOT Analysis
  16.3.5.5. Strategic Overview
  16.3.6. Eppendorf AG
  16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.6.2. Product Portfolio
  16.3.6.3. Financial Overview
  16.3.6.4. SWOT Analysis
  16.3.6.5. Strategic Overview
  16.3.7. Parker Hannifin Corporation
  16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.7.2. Product Portfolio
  16.3.7.3. Financial Overview
  16.3.7.4. SWOT Analysis
  16.3.7.5. Strategic Overview
  16.3.8. PBS Biotech, Inc.
  16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.8.2. Product Portfolio
  16.3.8.3. Financial Overview
  16.3.8.4. SWOT Analysis
  16.3.8.5. Strategic Overview
  16.3.9. Distek, Inc.
  16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.9.2. Product Portfolio
  16.3.9.3. Financial Overview
  16.3.9.4. SWOT Analysis
  16.3.9.5. Strategic Overview
  16.3.10. Getinge
  16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.10.2. Product Portfolio
  16.3.10.3. Financial Overview
  16.3.10.4. SWOT Analysis
  16.3.10.5. Strategic Overview
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.